Edward Mallinckrodt Jr. Foundation
A St. Louis foundation established in 1953 to back early-career investigators in basic and translational biomedical science, funding the researchers others consider too unproven to trust.
Financial profile
Edward Mallinckrodt Jr. Foundation · EIN 43-6030295 · 501(c)(3)
| Fiscal year | Total revenue | Contributions | Program services | Total expenses | Net assets | Year end |
|---|---|---|---|---|---|---|
| FY2023 | $3,482,487 | $2,525,467 | $46,997,405 | Sep 2023 | ||
| FY2022 | $1,857,803 | $1,877,005 | $45,471,461 | Sep 2022 | ||
| FY2021 | $7,689,496 | $2,735,071 | $54,992,229 | Sep 2021 | ||
| FY2020 | $2,528,614 | $2,248,336 | $46,996,034 | Sep 2020 | ||
| FY2019 | $1,926,739 | $2,496,809 | $46,736,218 | Sep 2019 | ||
| FY2015 | $825,457 | $2,802,267 | $42,376,603 | Sep 2015 |
Figures exactly as reported. A blank cell was blank on the form. The fiscal year links to the filing.
Peer societies
Five societies Edward Mallinckrodt Jr. Foundation is read alongside.
WF
Whitehall Foundation
A foundation that since 1937 has funded basic research in vertebrate and invertebrate neurobiology, backing…
EUPF
Elsa U. Pardee Foundation
A foundation established in 1944 from Elsa Pardee's estate for the promotion of the control and cure of…
AMF
Ambrose Monell Foundation
A New York foundation supporting early stage research and social initiatives in medicine and science, backing…
GUVF
G. Unger Vetlesen Foundation
An endowed foundation that funds early-stage scientific research and conservation to build a more creative…
OPF
Ono Pharma Foundation
A corporate linked science foundation whose Ono Initiative funds high risk, high reward research in chemical…
Who backs EMJF
No public supporter list found as of September 2026.
The outside view
A St. Louis foundation established in 1953 to back early-career investigators in basic and translational biomedical science, funding the researchers others consider too unproven to trust.
- Authority
- Build
- Outward
- Operational
Their shape
The Frontier
At home at the edge of what comes next.
The Frontier is restless and pioneering, always testing what comes next. Its gift is innovation and adaptability, its challenge is focus, and not leaving its longtime members behind.
Also reads toward The Legacy and The Citadel.
Strengths
Not an official page of Edward Mallinckrodt Jr. Foundation. Sociogene does not consult. Everything here comes from public sources, dated and linked. Something wrong here? Tell us what we missed.